Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach.
Wirth, Klaus J, Scheibenbogen, Carmen · Medicina (Kaunas, Lithuania) · 2022 · DOI
Quick Summary
Many people with post-COVID syndrome experience shortness of breath and chest pain, even though their lungs and heart are typically healthy. This study proposes that the problem may stem from overbreathing (hyperventilation) during exercise, combined with problems in how the body regulates breathing and uses energy in muscles. The authors suggest that overbreathing creates a harmful cascade inside cells—disrupting sodium and calcium balance—which worsens fatigue and breathing difficulties. Preventing overbreathing might be a way to help these patients recover.
Why It Matters
This study bridges post-COVID syndrome and ME/CFS by proposing a unifying mechanistic explanation for breathing difficulties and exercise intolerance seen in both conditions. Understanding the cellular basis of hyperventilation-driven pathology could guide development of targeted interventions (such as breathing retraining) that prevent the cascade of sodium and calcium dysregulation. For ME/CFS patients, it offers a testable biological hypothesis that may apply more broadly to post-infectious fatigue syndromes.
Observed Findings
• Dyspnea and chest pain occur frequently in post-COVID syndrome despite absence of organ structural damage in most mild cases
• Hyperventilation occurs early during exercise in PCS patients
• Skeletal muscle energetic impairment and autonomic dysfunction are present in both PCS and ME/CFS
Inferred Conclusions
• Exaggerated respiratory response in PCS arises from combined skeletal muscle bioenergetic dysfunction and autonomic dysregulation
• Hyperventilation-induced respiratory alkalosis triggers intracellular sodium accumulation via NHE1 and other mechanisms, compounding existing sodium loading
• Mitochondrial calcium overload driven by high intracellular sodium is a key pathogenic mechanism linking breathing dysfunction to fatigue chronification
• Prevention of hyperventilation may represent a therapeutic target to interrupt this cascade
Remaining Questions
• Has hyperventilation been directly measured and quantified in post-COVID patients during standardized exercise testing?
• Can interventions that prevent hyperventilation (e.g., breathing retraining, pharmacologic approaches) improve dyspnea and exercise tolerance in PCS or ME/CFS patients?
• Do intracellular sodium and mitochondrial calcium levels correlate with symptom severity in these patient populations, and can these be measured non-invasively?
What This Study Does Not Prove
This is a theoretical mechanistic review without direct empirical data, so it does not prove these mechanisms actually occur in post-COVID or ME/CFS patients. The study does not demonstrate that preventing hyperventilation will clinically improve patient outcomes. Correlation between proposed mechanisms and symptom severity has not been established in patient populations.